Also listed on Werewolf Therapeutics, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends May 14, 2039 · Low confidence
20-year base term ends May 14, 2039
May 14, 2019
May 14, 2039
May 5, 2026
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 0 of 3 maintenance fees are paid so far. Confidence: Low. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 14, 2019, when application PCT/US2019/032320, the earliest non-provisional in its chain, was filed (this one was filed Mar 11, 2024); a parent in its chain could not be resolved (the next row) | May 14, 2039 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 12,036,266) | resolves to May 14, 2039, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Further caveats on record | The record names parents not resolved: 17028643, 17028643 | Low confidence overall | Low confidence |
| Computed term end | The steps above, in order | May 14, 2039 | Low confidence |
This family
| Application PCT/US2019/032320 | PCT application no patent term | no patent term |
| Application 17/028,643 | Abandoned not computed | not computed |
| Application 18/312,245 | Pending not computed | not computed |
| US 12,617,829 | this patent May 2039 | May 2039 |
| Application 19/562,226 | Pending not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Mar 19, 2024 Reel 66830, frame 509 | Winston, William; Brodkin, Heather; Seidel-dugan, Cynthia; Hicklin, Daniel; Salmeron-garcia, Jose Andres | Werewolf Therapeutics, Inc. | Assignment of Assignor's Interest |
| Oct 15, 2026 Reel 76677, frame 66 | Werewolf Therapeutics, Inc. | EMD Serono Research & Development Institute, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 12,036,266, ends no earlier than this term, so it caps nothing.